Cheap Growth Stocks: Value Hiding in a Pricey Market

The S&P 500's price-to-sales ratio is hovering near record territory, a headline that typically sends value investors running for cover. Yet the index-level multiple is a distorted lens. A handful of mega-cap names carry an outsized share of the market's total revenue valuation, leaving the median stock — and a meaningful slice of the growth universe — trading at levels that look far more reasonable against their own historical norms.

This bifurcation is the story of the current tape. Concentration at the top has inflated the aggregate metric, while many mid-cap and smaller growth names have seen their multiples compress over the past several quarters. For investors, the practical takeaway is that the index's richness says little about individual opportunity. Screening for growth companies with stable revenue trajectories and expanding margins can surface names trading at a discount to both their sector peers and their own five-year averages.

The filter matters more than the multiple

The obvious caveat is that cheap growth can stay cheap. A low price-to-sales ratio alone is not a catalyst. The durable edge comes from pairing valuation with fundamentals: accelerating revenue growth, improving free cash flow conversion, and a balance sheet that funds expansion without dilution. Companies that check those boxes while trading below their historical norms offer a margin of safety that the index average simply does not provide.

Sector rotation also plays a role. Software, biotech, and select industrials have experienced meaningful de-rating even as their underlying businesses continue to compound. When the broad market is priced for perfection, the asymmetry shifts toward names where expectations are already modest. The takeaway for traders is straightforward: ignore the index headline, and let stock-specific valuation and growth do the talking.